Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Betaferon Treatment and Exercise Data Gathering IN Early MS.

Trial Profile

Betaferon Treatment and Exercise Data Gathering IN Early MS.

Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2015

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms BEGIN
  • Sponsors Bayer
  • Most Recent Events

    • 23 Jun 2015 Follow-up at 2-years (n=220 CIS+346 RRMS patients),results presented at the 1st Congress of the European Academy of Neurology.
    • 10 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 10 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top